A comparison of the in vitro experiments with ex vivo experiments leads to the conclusion that in myotubes, NLRP3 is regulated independently from infiltrative immune cells or fibroblasts upon pro-inflammatory conditions, as occurring in IBM pathology. The gene discussed is NLRP3; the disease is inclusion body myositis.